Catherine Ramsey
Stock Analyst at Baird
(3.32)
# 979
Out of 5,182 analysts
55
Total ratings
42.86%
Success rate
7.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Outperform | $239 → $257 | $193.03 | +33.14% | 7 | Feb 27, 2026 | |
| CSTL Castle Biosciences | Maintains: Outperform | $41 → $44 | $23.13 | +90.23% | 10 | Feb 27, 2026 | |
| ILMN Illumina | Maintains: Neutral | $105 → $109 | $120.93 | -9.87% | 7 | Oct 31, 2025 | |
| RVTY Revvity | Maintains: Outperform | $122 → $123 | $89.79 | +36.99% | 6 | Oct 28, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $320.00 | +10.00% | 11 | Jul 16, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $47.91 | -8.16% | 7 | May 6, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $496.11 | +34.04% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $115.06 | +39.06% | 5 | Aug 17, 2022 |
Natera
Feb 27, 2026
Maintains: Outperform
Price Target: $239 → $257
Current: $193.03
Upside: +33.14%
Castle Biosciences
Feb 27, 2026
Maintains: Outperform
Price Target: $41 → $44
Current: $23.13
Upside: +90.23%
Illumina
Oct 31, 2025
Maintains: Neutral
Price Target: $105 → $109
Current: $120.93
Upside: -9.87%
Revvity
Oct 28, 2025
Maintains: Outperform
Price Target: $122 → $123
Current: $89.79
Upside: +36.99%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $320.00
Upside: +10.00%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $47.91
Upside: -8.16%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $496.11
Upside: +34.04%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $115.06
Upside: +39.06%